Microdosing of Psychoactive Substances in Business Practice
Businesses – December 06, 2021
Source: OpenAlex
Summary
Remarkably, microdosing **drugs of abuse** like LSD and cocaine allows individuals to sustain a subtle psychoactive effect through the work week, avoiding significant behavioral changes or withdrawal. This **dosing** strategy, unlike standard use, even sees stimulants require progressively lower doses over time for the same effect, a fascinating **pharmacology** insight. Conversely, **psychedelics** develop resistance. Through **case studies** examining **psychology** and initial **biochemical analysis** in corporate environments, this approach's influence on business managers and creatives is being explored, revealing a unique pattern of substance interaction.
Abstract
Abusing psychoactive substances has been a popular sport in the business world since the mid-19th century. First, they were appreciated for their stimulating or tonic effects, but later with psychedelics on the scene, their importance in subculture matured. In the last decade, it has become very popular to use LSD and cocaine in subtle doses, which provides users with a high that is enough to feel their psychoactive potential, but not as high that significant behavioral changes can be seen. Unlike regular use, microdosing is usually sufficient to affect a few without undue finish and withdrawal symptoms. It allows for abuse in the regular mode of the working week with a rest phase on the weekend. The diametric difference between the abuse of standard dosing and micro-dosing is also in the decreasing tolerance of the organism. Over time, an organism permanently exposed to microdosing of stimulants is sufficient to achieve a gradually decreasing dose effect that psychedelics develop resistance to. Case studies of such prolonged use were described and analyzed to show the role of microdosing in the creative world and for business managers. Initial field research, funded by the Newton University internal grant, focused on contamination mapping in office spaces for employees in target positions. Further research continues on the investigation of microdosing in conditions of corporate reality.